Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Mixed-size DNA fragments in a blood sample may predict residual cancer as well as MRI scans.
After a median follow-up of 13 months, four of the five patients had ongoing complete remission.
Higher rates of anxiety and depression are associated with higher mortality risk among women with ovarian cancer.
Men with a high genetic risk of prostate cancer can reduce their risk of developing a lethal form of the disease by healthy living.
Colorectal cancer in people under 50 has risen dramatically in recent decades.
People living with cancer are at higher risk for severe illness and death due to COVID-19.
Older women who did not receive radiation after breast-conserving surgery had similar 10-year survival rates.
Symptom under-recognition may be more common among younger patients and Black patients.
A simple blood test can reveal treatment response faster than conventional imaging scans.
Study finds that deaths from cancer accounted for more than 4 million potential years of life lost in 2017
The report highlights how cancer research is extending and improving lives and includes a special feature on COVID-19 and cancer challenges.
For each cancer type studied, mortality was between 11% and 50% higher in the counties with persistent poverty.
New report highlights cancer’s toll on racial and ethnic minorities and other underserved populations.
A Phase 1 study on customized immunotherapy shows promise for people with lung cancer.
Premenopausal women with breast cancer who had been treated with radiation for a childhood cancer had worse breast cancer-specific survival.
Radiation for the treatment of childhood cancer may have long-term effects on cardiovascular and metabolic health.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.